CLINICAL TRIALS TO VALIDATE AI-DRIVEN DRUG REPURPOSING

This RFP seeks investigator-initiated Phase I or IIA proof- of-concept trials to validate AI-driven drug repurposing for unsolved diseases, using already approved therapies.

Sign in or register for free to read the full details and apply

Share:

All funding opportunities